Effect of vitrectomy with intravitreal Conbercept injection for polypoidal choroidal vasculopathy associated with vitreous hemorrhage

Effect of vitrectomy with intravitreal Conbercept injection for polypoidal choroidal vasculopathy associated with vitreous hemorrhage

AIM: To investigate the clinical effect of vitrectomy combined with intravitreal injection of Conbercept for polypoidal choroidal vasculopathy(PCV)associated with vitreous hemorrhage. <p>METHODS: The clinical data of 59 patients(59 eyes)underwent vitrectomy in a hospital from May 2013 to Augus...

Full description

Bibliographic Details
Main Authors:	Jian Shen, Li-Ping Xu, Xiang-Jun Meng, Ming Zhou
Format:	Article
Language:	English
Published:	Press of International Journal of Ophthalmology (IJO PRESS) 2018-09-01
Series:	Guoji Yanke Zazhi
Subjects:	polypoidal choroidal vasculopathy vitreous hemorrhage vitrectomy conbercept
Online Access:	http://ies.ijo.cn/cn_publish/2018/9/201809023.pdf

Similar Items

Effect of intravitreal Conbercept on wet age-related macular degeneration and polypoidal choroidal vasculopathy
by: Ying-Chun Li, et al.
Published: (2015-11-01)

Long-term observation of vitrectomy without subretinal hemorrhage management for massive vitreous hemorrhage secondary to polypoidal choroidal vasculopathy
by: Zhi-Xi Li, et al.
Published: (2019-12-01)

Observation of polypoidal choroidal vasculopathy with vitreous hemorrhage treated by microincision 25G pars plana vitrectomy
by: Yan Yang, et al.
Published: (2020-03-01)

Sympathetic ophthalmia in fellow eye after vitrectomy for massive subretinal hemorrhage secondary to polypoidal choroidal vasculopathy
by: Suetsugu T, et al.
Published: (2018-10-01)

Comparison of the 1-year Outcomes of Conbercept Therapy between Two Different Angiographic Subtypes of Polypoidal Choroidal Vasculopathy
by: Yong Cheng, et al.
Published: (2016-01-01)

Comparison of the efficacy of two Conbercept regimens in the treatment of polypoid choroidal angiopathy
by: Zhou-Peng Liao, et al.
Published: (2020-03-01)

Effect and safety of PPV assisted by intravitreal injection of Conbercept in the treatment of PDR combined with vitreous hemorrhage
by: Chun-Shi Li, et al.
Published: (2021-09-01)

Effect of Conbercept on treating polypoidal choroidal vasculopathy and its effect on hemorheology of patients
by: Ayinu·Nulahou, et al.
Published: (2020-04-01)

The effect of adjunctive intravitreal conbercept at the end of diabetic vitrectomy for the prevention of post-vitrectomy hemorrhage in patients with severe proliferative diabetic retinopathy: a prospective, randomized pilot study
by: Tingting Jiang, et al.
Published: (2020-02-01)

One-year outcomes of intravitreal conbercept combined rescue therapy for polypoidal choroidal vasculopathy in a Chinese population: a real-life clinical data
by: Hui-Jun Qi, et al.
Published: (2019-01-01)

Progress in treatment of submacular hemorrhage due to polypoid choroidal vasculopathy
by: Shuang Zhang, et al.
Published: (2019-06-01)

Clinical features and progress of surgical therapy for polypoidal choroidal vasculopathy
by: Qing Ren, et al.
Published: (2018-10-01)

Activation of quiescent polypoidal choroidal vasculopathy after membrane peeling vitrectomy for epiretinal membrane: a case report
by: Yuelin Wang, et al.
Published: (2021-09-01)

Effects of three consecutive monthly intravitreal injection of ranibizumab for polypoidal choroidal vasculopathy in Korea
by: Young Gun Park, et al.
Published: (2015-04-01)

Effect of intravitreal conbercept treatment before vitrectomy in proliferative diabetic retinopathy
by: Jian-Bo Mao, et al.
Published: (2018-07-01)

Short-term effects of intravitreal Conbercept for choroidal neovascularization secondary to high myopia
by: Jie-Yun He, et al.
Published: (2018-12-01)

Sub-internal limiting membrane hemorrhage as an unusual presentation of polypoidal choroidal vasculopathy
by: George Joseph Manayath, et al.
Published: (2021-01-01)

Clinical implications of pachyvessels in polypoidal choroidal vasculopathy
by: Nobuo Ijuin, et al.
Published: (2020-04-01)

Effects of intravitreal injection Conbercept combined with 23G minimally invasive vitrectomy on PDR
by: Gui-Jun Luo, et al.
Published: (2018-07-01)

Eplerenone in the Treatment of Polypoidal Choroidal Vasculopathy
by: Kapil G. Kapoor, et al.
Published: (2015-12-01)

Short-term efficacy of intravitreal conbercept in treatment-naive patients with polypoidal choroidal vasculopathy
by: Peng Y, et al.
Published: (2018-02-01)

Photodynamic Therapy and Bevacizumab Combination for Polypoidal Choroidal Vasculopathy Refractory to Intravitreal Ranibizumab
by: Zeynep Alkin, et al.
Published: (2016-12-01)

Incidence, outcomes, and risk factors for hemorrhagic complications in eyes with polypoidal choroidal vasculopathy following photodynamic therapy in Indian subjects
by: Pukhraj Rishi, et al.
Published: (2017-01-01)

Effect of intravitreal injection of conbercept on neovascular age-related macular degeneration
by: Tao Li, et al.
Published: (2019-04-01)

Curative effect of compound Xuesaitong combined with Conbercept in the treatment of choroidal neovascularization in pathological myopia
by: He-Ling Huang, et al.
Published: (2017-06-01)

Efficacy of intravitreal aflibercept injections for Japanese patients with polypoidal choroidal vasculopathy
by: Arakawa A, et al.
Published: (2017-04-01)

Effects of vitrectomy with preoperative intravitreal Conbercept for proliferative diabetic retinopathy
by: Huai-Sheng Zhou, et al.
Published: (2018-02-01)

Choroidal Nevus in an Eye with Polypoidal Choroidal Vasculopathy
by: Kazunobu Asao, et al.
Published: (2014-12-01)

Effect of Epiretinal Membrane Peeling on Intravitreal Aflibercept Therapy Response for Polypoidal Choroidal Vasculopathy: A Case Report
by: Aslı Kırmacı, et al.
Published: (2018-04-01)

Treatment Outcomes in Patients with Polypoidal Choroidal Vasculopathy
by: Mümin Hocaoğlu, et al.
Published: (2016-01-01)

Intravitreal injection of Conbercept-assisted vitrectomy for the treatment of proliferative diabetic retinopathy and its effects on inflammatory factors and ANGPTL4 in the vitreous
by: Si-Hua Cheng, et al.
Published: (2019-12-01)

Comparison of intravitreal ziv-aflibercept and bevacizumab monotherapy in treatment-naive polypoidal choroidal vasculopathy
by: Sumit Randhir Singh, et al.
Published: (2019-01-01)

Characteristics of Fundus Autofluorescence in Active Polypoidal Choroidal Vasculopathy
by: Zafer Öztaş, et al.
Published: (2016-08-01)

Clinical efficacy of Conbercept combined with vitrectomy for proliferative vitreoretinopathy after choroidal detachment
by: Xiu-Zhen Shi, et al.
Published: (2018-12-01)

Therapeutic effects of ranibizumab in patients with polypoidal choroidal vasculopathy
by: Xiaoya Gu, et al.
Published: (2019-07-01)

Polypoidal Choroidal Vasculopathy Associated with Optic Disc Coloboma
by: Yumiko Nakano, et al.
Published: (2018-01-01)

Comparison of Outcomes between 3 Monthly Brolucizumab and Aflibercept Injections for Polypoidal Choroidal Vasculopathy
by: Yoshiko Fukuda, et al.
Published: (2021-09-01)

Peripheral Exudative Hemorrhagic Chorioretinopathy: A Variant of Polypoidal Choroidal Vasculopathy?
by: Arman Mashayekhi, et al.
Published: (2013-01-01)

Clinical effect of 25G+ vitrectomy combined with intravitreal injection of Conbercept in the treatment of severe proliferative diabetic retinopathy
by: Yong-Mou Zhou, et al.
Published: (2017-12-01)

One-year outcome of combination therapy with intravitreal aflibercept and photodynamic therapy for polypoidal choroidal vasculopathy
by: Hsin-Yu Weng, et al.
Published: (2019-05-01)